This review of the familial tumor syndromes involving the endocrine organs is focused on
discussing the main updates on the upcoming fifth edition of the WHO Classification of …

Familial non-medullary thyroid cancer (FNMTC) constitutes 3–9% of all thyroid cancers. Out
of all FNMTC cases, only 5% in the syndromic form has well-studied driver germline …

Context: By genome-wide association studies, the risk allele [A] of SNP rs965513
predisposes strongly to papillary thyroid carcinoma (PTC). It is located in a gene-poor region …

Non-medullary thyroid cancer (NMTC) is the most common type of thyroid cancer. With the
increasing incidence of NMTC in recent years, the familial form of the disease has also …

Considering the rising incidence and mortality of thyroid cancer (TC) worldwide, the aim of
our study was to determine the risk factors for TC in a province with the highest incidence of …

The [A] allele of SNP rs965513 in 9q22 has been consistently shown to be highly associated
with increased papillary thyroid cancer (PTC) risk with an odds ratio of∼ 1.8 as determined …

Cancer derived from thyroid follicular epithelial cells is common; it represents the most
common endocrine malignancy. The molecular features of sporadic tumors have been …

The incidence of thyroid cancer has increased in eastern Europe since the Chernobyl
nuclear power plant accident. Although the radioactive fallout was much less severe and the …

Familial aggregation is a significant risk factor for the development of thyroid cancer and
familial non‐medullary thyroid cancer (FNMTC) accounts for 5–7% of all NMTC. Whole …

Background: Familial non-medullary thyroid carcinoma (FNMTC) is a genetically
predisposed disease with unclear genetic mechanisms. This makes research on …